• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过心血管磁共振成像对心肌病进行全面评估:聚焦儿科人群

A Comprehensive Assessment of Cardiomyopathies through Cardiovascular Magnetic Resonance: Focus on the Pediatric Population.

作者信息

Baessato Francesca, Romeo Cristina, Rabbat Mark G, Pontone Gianluca, Meierhofer Christian

机构信息

Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, 80636 Munich, Germany.

Department of Cardiology, Regional Hospital S. Maurizio, 39100 Bolzano, Italy.

出版信息

Diagnostics (Basel). 2022 Apr 19;12(5):1022. doi: 10.3390/diagnostics12051022.

DOI:10.3390/diagnostics12051022
PMID:35626178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9139185/
Abstract

Cardiomyopathies (CMPs) are a heterogeneous group of diseases that involve the myocardium and result in systolic or diastolic impairment of the cardiac muscle, potentially leading to heart failure, malignant arrhythmias, or sudden cardiac death. Occurrence in pediatric age is rare but has been associated with worse outcomes. Non-invasive cardiac imaging techniques, integrated with clinical, genetic, and electrocardiographic data, have shown a pivotal role in the clinical work-up of such diseases by defining structural alterations and assessing potential complications. Above all modalities, cardiovascular magnetic resonance (CMR) has emerged as a powerful tool complementary to echocardiography to confirm diagnosis, provide prognostic information and guide therapeutic strategies secondary to its high spatial and temporal resolution, lack of ionizing radiation, and good reproducibility. Moreover, CMR can provide in vivo tissue characterization of the myocardial tissue aiding the identification of structural pathologic changes such as replacement or diffuse fibrosis, which are predictors of worse outcomes. Large prospective randomized studies are needed for further validation of CMR in the context of childhood CMPs. This review aims to highlight the role of advanced imaging with CMR in CMPs with particular reference to the dilated, hypertrophic and non-compacted phenotypes, which are more commonly seen in children.

摘要

心肌病(CMPs)是一组异质性疾病,累及心肌,导致心肌收缩或舒张功能受损,可能引发心力衰竭、恶性心律失常或心源性猝死。儿科患者中发病率较低,但预后较差。非侵入性心脏成像技术与临床、基因和心电图数据相结合,通过明确结构改变和评估潜在并发症,在这些疾病的临床检查中发挥了关键作用。在所有检查方式中,心血管磁共振成像(CMR)已成为一种强大的工具,可作为超声心动图的补充,因其具有高空间和时间分辨率、无电离辐射且重复性好,有助于确诊、提供预后信息并指导治疗策略。此外,CMR能够对心肌组织进行活体组织特征分析,有助于识别诸如替代性或弥漫性纤维化等结构病理变化,这些变化是预后较差的预测指标。在儿童CMPs的背景下,还需要大型前瞻性随机研究来进一步验证CMR的作用。本综述旨在强调CMR等先进成像技术在CMPs中的作用,特别提及扩张型、肥厚型和未致密化型表型,这些在儿童中更为常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/475b4bb15dbd/diagnostics-12-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/11c8eb00392f/diagnostics-12-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/48b8a15e3910/diagnostics-12-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/475b4bb15dbd/diagnostics-12-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/11c8eb00392f/diagnostics-12-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/48b8a15e3910/diagnostics-12-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f02/9139185/475b4bb15dbd/diagnostics-12-01022-g003.jpg

相似文献

1
A Comprehensive Assessment of Cardiomyopathies through Cardiovascular Magnetic Resonance: Focus on the Pediatric Population.通过心血管磁共振成像对心肌病进行全面评估:聚焦儿科人群
Diagnostics (Basel). 2022 Apr 19;12(5):1022. doi: 10.3390/diagnostics12051022.
2
The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping.根据新指南探讨磁共振成像在心肌病中的作用:聚焦组织成像
J Clin Med. 2024 Apr 29;13(9):2621. doi: 10.3390/jcm13092621.
3
Advanced Non-invasive Imaging Techniques in Chronic Heart Failure and Cardiomyopathies : Focus on Cardiac Magnetic Resonance Imaging and Computed Tomographic.慢性心力衰竭和心肌病的先进无创成像技术:重点关注心脏磁共振成像和计算机断层扫描。
Adv Exp Med Biol. 2018;1067:183-196. doi: 10.1007/5584_2018_183.
4
Early diagnosis of cardiomyopathies by cardiac magnetic resonance. Overview of the main criteria.心脏磁共振对心肌病的早期诊断。主要标准概述。
Monaldi Arch Chest Dis. 2022 Apr 11;92(4). doi: 10.4081/monaldi.2022.2151.
5
Value of cardiac magnetic resonance on the risk stratification of cardiomyopathies.心脏磁共振成像在心肌病风险分层中的价值。
World J Cardiol. 2023 Oct 26;15(10):487-499. doi: 10.4330/wjc.v15.i10.487.
6
Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌存活性的磁共振成像(MRI):一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(15):1-45. Epub 2010 Jul 1.
7
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).恰加斯病的多模态成像评估:巴西心血管成像部(DIC)与欧洲心血管成像协会(EACVI)的专家共识
Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):459-460n. doi: 10.1093/ehjci/jex154.
8
Cardiovascular magnetic resonance: contribution to the exploration of cardiomyopathies.心血管磁共振成像:对心肌病诊断的贡献
Med Pharm Rep. 2019 Oct;92(4):326-336. doi: 10.15386/mpr-1343. Epub 2019 Oct 25.
9
The usefulness of cardiovascular magnetic resonance imaging in children with myocardial diseases.心血管磁共振成像在患有心肌疾病儿童中的应用价值。
Kardiol Pol. 2015;73(6):419-28. doi: 10.5603/KP.a2014.0239. Epub 2015 Jan 7.
10
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.超声心动图与心脏磁共振成像在肥厚型心肌病中的互补作用
Curr Cardiol Rep. 2017 Sep;19(9):81. doi: 10.1007/s11886-017-0897-z.

引用本文的文献

1
Cardiac Hypertrophy: A Comprehensive Review from Prenatal Life to Young Adulthood.心脏肥大:从胎儿期到青年期的全面综述
Children (Basel). 2025 Jul 28;12(8):989. doi: 10.3390/children12080989.
2
Cardiomyopathy in Children and Adolescents in the Era of Precision Medicine.精准医学时代的儿童和青少年心肌病。
Arq Bras Cardiol. 2024 Sep;121(9):e20230154. doi: 10.36660/abc.20230154.
3
Myocardial hypertrophy: the differentiation of uremic, hypertensive, and hypertrophic cardiomyopathies by cardiac MRI.心肌肥厚:通过心脏磁共振成像鉴别尿毒症性、高血压性和肥厚性心肌病

本文引用的文献

1
Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging.通过心脏磁共振成像对心肌病(扩张型、肥厚型和致心律失常性心肌病)进行危险分层。
Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E118-E122. doi: 10.1093/eurheartj/suab105. eCollection 2021 Oct.
2
The Potential Role of Cardiac CT in the Evaluation of Patients With Known or Suspected Cardiomyopathy: From Traditional Indications to Novel Clinical Applications.心脏CT在已知或疑似心肌病患者评估中的潜在作用:从传统适应证到新型临床应用
Front Cardiovasc Med. 2021 Sep 14;8:709124. doi: 10.3389/fcvm.2021.709124. eCollection 2021.
3
Insights Imaging. 2024 Aug 1;15(1):190. doi: 10.1186/s13244-024-01770-0.
4
The Role of Multimodality Imaging in Pediatric Cardiomyopathies.多模态成像在儿童心肌病中的作用
J Clin Med. 2023 Jul 24;12(14):4866. doi: 10.3390/jcm12144866.
5
The Establishment of Hypertrophic Cardiomyopathy Diagnosis Model via Artificial Neural Network and Random Decision Forest Method.基于人工神经网络和随机决策森林方法的肥厚型心肌病诊断模型的建立。
Mediators Inflamm. 2022 Sep 15;2022:2024974. doi: 10.1155/2022/2024974. eCollection 2022.
Cardiac Magnetic Resonance Tissue Characterization in Ischemic Cardiomyopathy.
缺血性心肌病的心脏磁共振组织特征。
J Thorac Imaging. 2022 Jan 1;37(1):2-16. doi: 10.1097/RTI.0000000000000621.
4
Feasibility of late gadolinium enhancement (LGE) in ischemic cardiomyopathy using 2D-multisegment LGE combined with artificial intelligence reconstruction deep learning noise reduction algorithm.基于 2D 多节段钆延迟增强(LGE)联合人工智能重建深度学习降噪算法评估缺血性心肌病 LGE 的可行性。
Int J Cardiol. 2021 Nov 15;343:164-170. doi: 10.1016/j.ijcard.2021.09.012. Epub 2021 Sep 10.
5
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020年美国心脏协会/美国心脏病学会肥厚型心肌病患者诊断和治疗指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Thorac Cardiovasc Surg. 2021 Jul;162(1):e23-e106. doi: 10.1016/j.jtcvs.2021.04.001. Epub 2021 Apr 27.
6
Tumoral Phenocopies of Hypertrophic Cardiomyopathy: The Role of Cardiac Magnetic Resonance.肥厚型心肌病的肿瘤样表型:心脏磁共振成像的作用
J Clin Med. 2021 Apr 14;10(8):1683. doi: 10.3390/jcm10081683.
7
T1 mapping and conditional survival in paediatric dilated cardiomyopathy with advanced heart failure.T1 映射与晚期心力衰竭儿童扩张型心肌病的条件生存。
Cardiol Young. 2021 Dec;31(12):1938-1942. doi: 10.1017/S1047951121001268. Epub 2021 Apr 8.
8
Diagnostic value of left atrial strain in pediatric hypertrophic cardiomyopathy with normal maximum left atrial volume index: preliminary cardiac magnetic resonance study.左心房应变在最大左心房容积指数正常的小儿肥厚型心肌病中的诊断价值:初步心脏磁共振研究。
Pediatr Radiol. 2021 Apr;51(4):594-604. doi: 10.1007/s00247-020-04884-x. Epub 2021 Jan 20.
9
Reference ranges ("normal values") for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update.成人和儿童心血管磁共振(CMR)的参考范围(“正常值”):2020 更新。
J Cardiovasc Magn Reson. 2020 Dec 14;22(1):87. doi: 10.1186/s12968-020-00683-3.
10
SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.SCMR 立场文件(2020 年):心血管磁共振的临床适应证。
J Cardiovasc Magn Reson. 2020 Nov 9;22(1):76. doi: 10.1186/s12968-020-00682-4.